Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helium preconditioning and postconditioning in CABG surgery
NL-OMON31964Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of helium and sevoflurane in myocardial ischemia-reperfusion injury (5 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Myocardial signaling pathway molecule detection. Planned start Jun 2008; status: not yet recruiting.
02
Drugs
heliumsevoflurane
03
Conditions
myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on NL-OMON31964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31964.